Literature DB >> 4550499

Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease.

U K Rinne, V Sonninen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4550499     DOI: 10.1212/wnl.22.1.62

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

1.  Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602.

Authors:  G Campanella; S Algeri; C Cerletti; E Dolfini; A Jori; F Rinaldi
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

2.  A case of parkinsonism following striatal lacunar infarction.

Authors:  A Friedman; U J Kang; T K Tatemichi; R E Burke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-09       Impact factor: 10.154

Review 3.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

4.  Failure of cerebrospinal fluid homovanillic acid to predict levodopa response in Parkinson's disease.

Authors:  W J Weiner; H L Klawans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-10       Impact factor: 10.154

Review 5.  Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.

Authors:  Félix J Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  Front Cell Neurosci       Date:  2014-11-11       Impact factor: 5.505

6.  Neurochemical specificity of learning: dopamine and motor learning.

Authors:  W J McEntee; R G Mair; P J Langlais
Journal:  Yale J Biol Med       Date:  1987 Mar-Apr
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.